International Clinical Trial: Evaluating the Efficacy and Safety of Eculizumab in Acute Attacks of Neuromyelitis Optica Spectrum Disorders (NMOSD) in Real-World China: A Multicenter, Retrospective, Open-Label Study

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134650) titled 'Evaluating the Efficacy and Safety of Eculizumab in Acute Attacks of Neuromyelitis Optica Spectrum Disorders (NMOSD) in Real-World China: A Multicenter, Retrospective, Open-Label Study' on Oct. 19.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

Condition: AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder

Intervention: Eculizumab+IVMP Group:None Control group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Eculizumab+IVMP Group:60;Control group:60;Basic treat...